Cargando…

Aromatase inhibitors in stimulated IVF cycles

Aromatase inhibitors have been introduced as a new treatment modality that could challenge clomiphene citrate as an ovulation induction regiment in patients with PCOS. Although several randomized trials have been conducted regarding their use as ovulation induction agents, only few trials are availa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papanikolaou, Evangelos G, Polyzos, Nikolaos P, Humaidan, Peter, Pados, George, Bosch, Ernesto, Tournaye, Herman, Tarlatzis, Basil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150251/ https://www.ncbi.nlm.nih.gov/pubmed/21693033 http://dx.doi.org/10.1186/1477-7827-9-85

Ejemplares similares

New algorithm for OHSS prevention
por: Papanikolaou, Evangelos G, et al.
Publicado: (2011)

Aromatase inhibitors in post-menopausal endometriosis
por: Polyzos, Nikolaos P, et al.
Publicado: (2011)

Endometrial changes in estrogen and progesterone receptor expression during implantation in an oocyte donation program
por: Klonos, Eleftherios, et al.
Publicado: (2020)

ESHRE guideline: ovarian stimulation for IVF/ICSI(†)
por: Bosch, Ernesto, et al.
Publicado: (2020)

The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation
por: Drakopoulos, Panagiotis, et al.
Publicado: (2018)

Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI
por: Bosch, Ernesto, et al.
Publicado: (2020)

Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Broekmans, Frank, et al.
Publicado: (2021)

Fresh and cumulative live birth rates in mild versus conventional stimulation for IVF cycles in poor ovarian responders: a systematic review and meta-analysis
por: Montoya-Botero, Pedro, et al.
Publicado: (2021)

Intracytoplasmic morphologically selected sperm injection (IMSI): a critical and evidence-based review
por: De Vos, Anick, et al.
Publicado: (2013)

Corifollitropin α followed by menotropin for poor ovarian responders’ trial (COMPORT): a protocol of a multicentre randomised trial
por: Polyzos, Nikolaos P, et al.
Publicado: (2013)

A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol
por: Papanikolaou, Evangelos G., et al.
Publicado: (2018)

Fertility potential in a man with ankylosing spondylitis as revealed by semen analysis by light, electron and fluorescence microscopy
por: Chatzimeletiou, Katerina, et al.
Publicado: (2018)

Can ovarian double-stimulation in the same menstrual cycle improve IVF outcomes?
por: Cardoso, Maria Cecília de Almeida, et al.
Publicado: (2017)

Luteal Phase Support in IVF: Comparison Between Evidence-Based Medicine and Real-Life Practices
por: Di Guardo, Federica, et al.
Publicado: (2020)

High-Throughput Analysis of Ovarian Cycle Disruption by Mixtures of Aromatase Inhibitors
por: Bois, Frederic Y., et al.
Publicado: (2017)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Precautions for Patients Taking Aromatase Inhibitors
por: Heery, Mary, et al.
Publicado: (2020)

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos
por: Labarta, Elena, et al.
Publicado: (2017)

Corrigendum to “A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos”
por: Labarta, Elena, et al.
Publicado: (2017)

Molecular Docking of Aromatase Inhibitors
por: Suvannang, Naravut, et al.
Publicado: (2011)

Bone loss and the aromatase inhibitors
por: Lester, J, et al.
Publicado: (2005)

Aromatase inhibitors in male sex
por: Singh, Santosh Kumar
Publicado: (2013)

Aromatase inhibitors in the treatment of endometriosis
por: Słopień, Radosław, et al.
Publicado: (2016)

Aromatase Inhibitors in Erectile Dysfunction
por: Singh, Santosh
Publicado: (2021)

Developmental stage on day-5 and fragmentation rate on day-3 can influence the implantation potential of top-quality blastocysts in IVF cycles with single embryo transfer
por: della Ragione, Tiziana, et al.
Publicado: (2007)

The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM
por: Ortega-Hrepich, Carolina, et al.
Publicado: (2014)

Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates
por: Wood, Paul M, et al.
Publicado: (2011)

Significant Serum Progesterone Variations on the Day of Final Oocyte Maturation in Stimulated IVF Cycles
por: Shanker, Upma, et al.
Publicado: (2019)

Low Testosterone and Semen Parameters in Male Partners of Infertile Couples Undergoing IVF with a Total Sperm Count Greater than 5 Million
por: Di Guardo, Federica, et al.
Publicado: (2020)

Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis
por: Griesinger, Georg, et al.
Publicado: (2020)

The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment
por: Mitwally, Mohamed FM, et al.
Publicado: (2005)

Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005)

The effects of aromatase inhibitors on lipids and thrombosis
por: Bundred, N J
Publicado: (2005)

Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Management of aromatase inhibitor–induced arthralgia
por: Younus, J., et al.
Publicado: (2010)

Understanding the mechanisms of aromatase inhibitor resistance
por: Miller, William R, et al.
Publicado: (2012)

Use of aromatase inhibitors in practice of gynecology
por: Usluogullari, Betul, et al.
Publicado: (2015)

Safety of aromatase inhibitors in the adjuvant setting
por: Perez, Edith A.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_lgcnjrl39ahkt8ieiqlv7qtti4